Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Nutraplus India Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Nutraplus India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

    No Records Found

Key fundamentals

Evaluate the intrinsic value of Nutraplus India Ltd stock 

Name March-23 March-22 March-21 March-20 March-19
Assets -3.4753 -3.3296 -0.2982 97.4895 136.3093
Liabilities -3.4753 -3.3296 -0.2982 97.4895 136.3093
Equity 17.0455 17.0455 17.0455 17.0455 17.0455
Gross Profit -0.1278 -3.6514 -0.7023 -35.8366 12.6536
Net Profit -0.157 -3.0313 -24.5161 -47.8261 2.1893
Cash From Operating Activities 0.0166 -0.1328 -14.2531 9.0697 12.362
NPM(%) 0 -3091.9 -124955.078 -44.83 1.56
Revenue 0 0.098 0.0196 106.6681 139.5559
Expenses 0.1278 3.7494 0.7219 142.5047 126.9023
ROE(%) 2.99 57.86 468 912.98 -41.79

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Nutraplus India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 824.20 -1.99 11.65 1.20 1321.50 1.39
Lotus Eye Hospital and Institute Ltd 80.41 -0.74 338.42 4.37 14.01 0.62
Bharat Immunological and Biologicals Corporation Ltd 23.00 -1.41 0.00 9.07 -39.50 0.00
Astec Lifesciences Ltd 681.00 -1.58 0.00 4.12 -687.11 0.00

Company Info

NUTRAPLUS PRODUCTS (INDIA) LIMITED was originally incorporated as a private limited company on 6th February 1990 with the Registrar of Companies, Maharashtra at Bombay. It was subsequently converted into a Public Limited Company with effect from 13th June 1992 in terms of the resolution passed in the Extra Ordinary General Meeting of the Company held on 28th May 1992. The Company is implementing a project for the manufacture of veterinary bulk drugs namely Dimetridazole (DMZ) and Dinitolmide (DOT) at M.I.D.C., Tarapur. Initially the Company proposed to set up manufacturing facilities for manufacture of Methyl Nitro Imidazole, an intermediate of DMZ with installed capacity of 240 MT per annum at a cost of Rs.123.66 Lakhs, for which it was sanctioned a term Loan of Rs.60 Lakhs from Maharashtra State Financial Corporation (MSFC). But now the Company has decided to go in for production of Dimetridazole (DMZ) and Dinitolmide (DOT) with installed capacities of 160 MT and 300 MT respectively per annum due to high value addition in these products, than their intermediates, huge demand and export potential for these products, being veterinary bulk drugs and there being few units manufacturing these bulk drugs in the organised sector and also because these products are not under any government controls with regard to manufacturing, pricing, selling or distribution unlike other bulk drugs. 2014 -Company has changed its name from Nutraplus Products (India) Ltd to Nutraplus India Ltd. 2015 -The Company have opened a corporate office Nutraplus India Limited 201/202, 2nd Floor, Planet Industrial Estate, Subhash Road, Vile Parle (East), Mumbai - 400057. Whereas the Registered Office of the Company will remain the same i.e.:Nutraplus India Limited,Vakil Villa, 7-A, Society Road End, Jogeshwari (E), Mumbai - 400060 2016 -Nutraplus India as commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE.

NUTRAPLUS PRODUCTS (INDIA) LIMITED was originally incorporated as a private limited company on 6th February 1990 with the Registrar of Companies, Maharashtra at Bombay. It was subsequently converted into a Public Limited Company with effect from 13th June 1992 in terms of the resolution passed in the Extra Ordinary General Meeting of the Company held on 28th May 1992. The Company is implementing a project for the manufacture of veterinary bulk drugs namely Dimetridazole (DMZ) and Dinitolmide (DOT) at M.I.D.C., Tarapur. Initially the Company proposed to set up manufacturing facilities for manufacture of Methyl Nitro Imidazole, an intermediate of DMZ with installed capacity of 240 MT per annum at a cost of Rs.123.66 Lakhs, for which it was sanctioned a term Loan of Rs.60 Lakhs from Maharashtra State Financial Corporation (MSFC). But now the Company has decided to go in for production of Dimetridazole (DMZ) and Dinitolmide (DOT) with installed capacities of 160 MT and 300 MT respectively per annum due to high value addition in these products, than their intermediates, huge demand and export potential for these products, being veterinary bulk drugs and there being few units manufacturing these bulk drugs in the organised sector and also because these products are not under any government controls with regard to manufacturing, pricing, selling or distribution unlike other bulk drugs. 2014 -Company has changed its name from Nutraplus Products (India) Ltd to Nutraplus India Ltd. 2015 -The Company have opened a corporate office Nutraplus India Limited 201/202, 2nd Floor, Planet Industrial Estate, Subhash Road, Vile Parle (East), Mumbai - 400057. Whereas the Registered Office of the Company will remain the same i.e.:Nutraplus India Limited,Vakil Villa, 7-A, Society Road End, Jogeshwari (E), Mumbai - 400060 2016 -Nutraplus India as commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE.

Read More

Parent Organisation

Nutraplus India Ltd.

Founded

06/02/1990

Managing Director

Mr.Mukesh D Naik

NSE Symbol

FAQ

The current price of Nutraplus India Ltd is

The 52-week high for Nutraplus India Ltd is

The market capitalization of Nutraplus India Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Nutraplus India Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Nutraplus India Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nutraplus India Ltd shares.

The CEO of Nutraplus India Ltd is Mr.Mukesh D Naik, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT